nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A43—Dexamethasone—ankylosing spondylitis	0.293	0.378	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—ankylosing spondylitis	0.0884	0.114	CbGbCtD
Zalcitabine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0641	0.0828	CbGbCtD
Zalcitabine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0427	0.0551	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0427	0.0551	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—ankylosing spondylitis	0.0376	0.0485	CbGbCtD
Zalcitabine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.033	0.0426	CbGbCtD
Zalcitabine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.032	0.0413	CbGbCtD
Zalcitabine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.025	0.0323	CbGbCtD
Zalcitabine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0215	0.0277	CbGbCtD
Zalcitabine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0215	0.0277	CbGbCtD
Zalcitabine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0212	0.0273	CbGbCtD
Zalcitabine—CYP3A4—Prednisone—ankylosing spondylitis	0.02	0.0258	CbGbCtD
Zalcitabine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0196	0.0254	CbGbCtD
Zalcitabine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0125	0.0161	CbGbCtD
Zalcitabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.000551	0.0885	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.000542	0.0871	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.000542	0.0871	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000535	0.0859	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00053	0.0851	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.000526	0.0845	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000526	0.0845	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000514	0.0826	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.000503	0.0807	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.000491	0.0788	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.000488	0.0784	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.000476	0.0765	CbGdCrCtD
Zalcitabine—Alopecia—Betamethasone—ankylosing spondylitis	0.000271	0.00123	CcSEcCtD
Zalcitabine—Discomfort—Prednisolone—ankylosing spondylitis	0.000269	0.00122	CcSEcCtD
Zalcitabine—Hallucination—Prednisone—ankylosing spondylitis	0.000265	0.00121	CcSEcCtD
Zalcitabine—Malaise—Triamcinolone—ankylosing spondylitis	0.000265	0.00121	CcSEcCtD
Zalcitabine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000264	0.0012	CcSEcCtD
Zalcitabine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000264	0.0012	CcSEcCtD
Zalcitabine—Syncope—Triamcinolone—ankylosing spondylitis	0.000263	0.0012	CcSEcCtD
Zalcitabine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000263	0.0012	CcSEcCtD
Zalcitabine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000263	0.0012	CcSEcCtD
Zalcitabine—Oedema—Prednisolone—ankylosing spondylitis	0.000261	0.00119	CcSEcCtD
Zalcitabine—Dysuria—Methotrexate—ankylosing spondylitis	0.00026	0.00119	CcSEcCtD
Zalcitabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.00026	0.00119	CcSEcCtD
Zalcitabine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000258	0.00118	CcSEcCtD
Zalcitabine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000258	0.00117	CcSEcCtD
Zalcitabine—Shock—Prednisolone—ankylosing spondylitis	0.000256	0.00117	CcSEcCtD
Zalcitabine—Cough—Triamcinolone—ankylosing spondylitis	0.000256	0.00117	CcSEcCtD
Zalcitabine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000254	0.00116	CcSEcCtD
Zalcitabine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000254	0.00116	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000254	0.00116	CcSEcCtD
Zalcitabine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000254	0.00116	CcSEcCtD
Zalcitabine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000254	0.00116	CcSEcCtD
Zalcitabine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000253	0.00115	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000252	0.00115	CcSEcCtD
Zalcitabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.00025	0.00114	CcSEcCtD
Zalcitabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00025	0.00114	CcSEcCtD
Zalcitabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00025	0.00114	CcSEcCtD
Zalcitabine—Eye disorder—Prednisone—ankylosing spondylitis	0.000249	0.00114	CcSEcCtD
Zalcitabine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000249	0.00113	CcSEcCtD
Zalcitabine—Depression—Methotrexate—ankylosing spondylitis	0.000248	0.00113	CcSEcCtD
Zalcitabine—Flushing—Prednisone—ankylosing spondylitis	0.000247	0.00113	CcSEcCtD
Zalcitabine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000247	0.00113	CcSEcCtD
Zalcitabine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000247	0.00113	CcSEcCtD
Zalcitabine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000247	0.00113	CcSEcCtD
Zalcitabine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000247	0.00112	CcSEcCtD
Zalcitabine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000245	0.00111	CcSEcCtD
Zalcitabine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000241	0.0011	CcSEcCtD
Zalcitabine—Malaise—Betamethasone—ankylosing spondylitis	0.00024	0.00109	CcSEcCtD
Zalcitabine—Malaise—Dexamethasone—ankylosing spondylitis	0.00024	0.00109	CcSEcCtD
Zalcitabine—Oedema—Triamcinolone—ankylosing spondylitis	0.00024	0.00109	CcSEcCtD
Zalcitabine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000239	0.00109	CcSEcCtD
Zalcitabine—Vertigo—Betamethasone—ankylosing spondylitis	0.000239	0.00109	CcSEcCtD
Zalcitabine—Syncope—Betamethasone—ankylosing spondylitis	0.000239	0.00109	CcSEcCtD
Zalcitabine—Syncope—Dexamethasone—ankylosing spondylitis	0.000239	0.00109	CcSEcCtD
Zalcitabine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Zalcitabine—Infection—Triamcinolone—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Zalcitabine—Infection—Methylprednisolone—ankylosing spondylitis	0.000238	0.00108	CcSEcCtD
Zalcitabine—Shock—Triamcinolone—ankylosing spondylitis	0.000236	0.00107	CcSEcCtD
Zalcitabine—Insomnia—Prednisolone—ankylosing spondylitis	0.000236	0.00107	CcSEcCtD
Zalcitabine—Alopecia—Prednisone—ankylosing spondylitis	0.000236	0.00107	CcSEcCtD
Zalcitabine—Shock—Methylprednisolone—ankylosing spondylitis	0.000235	0.00107	CcSEcCtD
Zalcitabine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000234	0.00107	CcSEcCtD
Zalcitabine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000234	0.00107	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000234	0.00107	CcSEcCtD
Zalcitabine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000234	0.00107	CcSEcCtD
Zalcitabine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000233	0.00106	CcSEcCtD
Zalcitabine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000232	0.00106	CcSEcCtD
Zalcitabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000232	0.00106	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000231	0.00105	CcSEcCtD
Zalcitabine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000231	0.00105	CcSEcCtD
Zalcitabine—Convulsion—Betamethasone—ankylosing spondylitis	0.000231	0.00105	CcSEcCtD
Zalcitabine—Hypertension—Betamethasone—ankylosing spondylitis	0.00023	0.00105	CcSEcCtD
Zalcitabine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00023	0.00105	CcSEcCtD
Zalcitabine—Myalgia—Betamethasone—ankylosing spondylitis	0.000227	0.00103	CcSEcCtD
Zalcitabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000227	0.00103	CcSEcCtD
Zalcitabine—Anxiety—Betamethasone—ankylosing spondylitis	0.000226	0.00103	CcSEcCtD
Zalcitabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000226	0.00103	CcSEcCtD
Zalcitabine—Discomfort—Betamethasone—ankylosing spondylitis	0.000224	0.00102	CcSEcCtD
Zalcitabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000224	0.00102	CcSEcCtD
Zalcitabine—Pain—Prednisolone—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000221	0.00101	CcSEcCtD
Zalcitabine—Vision blurred—Prednisone—ankylosing spondylitis	0.000219	0.000997	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000218	0.000995	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000218	0.000993	CcSEcCtD
Zalcitabine—Oedema—Betamethasone—ankylosing spondylitis	0.000218	0.000991	CcSEcCtD
Zalcitabine—Oedema—Dexamethasone—ankylosing spondylitis	0.000218	0.000991	CcSEcCtD
Zalcitabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000217	0.000988	CcSEcCtD
Zalcitabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000216	0.000986	CcSEcCtD
Zalcitabine—Infection—Dexamethasone—ankylosing spondylitis	0.000216	0.000984	CcSEcCtD
Zalcitabine—Infection—Betamethasone—ankylosing spondylitis	0.000216	0.000984	CcSEcCtD
Zalcitabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000215	0.000981	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000215	0.000979	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000215	0.000978	CcSEcCtD
Zalcitabine—Anaemia—Prednisone—ankylosing spondylitis	0.000215	0.000977	CcSEcCtD
Zalcitabine—Shock—Dexamethasone—ankylosing spondylitis	0.000214	0.000975	CcSEcCtD
Zalcitabine—Shock—Betamethasone—ankylosing spondylitis	0.000214	0.000975	CcSEcCtD
Zalcitabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000214	0.000974	CcSEcCtD
Zalcitabine—Agitation—Prednisone—ankylosing spondylitis	0.000213	0.000972	CcSEcCtD
Zalcitabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000213	0.00097	CcSEcCtD
Zalcitabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000213	0.00097	CcSEcCtD
Zalcitabine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000212	0.000967	CcSEcCtD
Zalcitabine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000212	0.000967	CcSEcCtD
Zalcitabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000211	0.000961	CcSEcCtD
Zalcitabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000211	0.000959	CcSEcCtD
Zalcitabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00021	0.000958	CcSEcCtD
Zalcitabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00021	0.000958	CcSEcCtD
Zalcitabine—Malaise—Prednisone—ankylosing spondylitis	0.000209	0.000954	CcSEcCtD
Zalcitabine—Vertigo—Prednisone—ankylosing spondylitis	0.000209	0.00095	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000208	0.000949	CcSEcCtD
Zalcitabine—Syncope—Prednisone—ankylosing spondylitis	0.000208	0.000948	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000208	0.000947	CcSEcCtD
Zalcitabine—Anorexia—Betamethasone—ankylosing spondylitis	0.000207	0.000945	CcSEcCtD
Zalcitabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000207	0.000945	CcSEcCtD
Zalcitabine—Urticaria—Prednisolone—ankylosing spondylitis	0.000207	0.000943	CcSEcCtD
Zalcitabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000207	0.000942	CcSEcCtD
Zalcitabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000206	0.000939	CcSEcCtD
Zalcitabine—Pain—Triamcinolone—ankylosing spondylitis	0.000205	0.000934	CcSEcCtD
Zalcitabine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000204	0.000929	CcSEcCtD
Zalcitabine—Convulsion—Prednisone—ankylosing spondylitis	0.000201	0.000916	CcSEcCtD
Zalcitabine—Hypertension—Prednisone—ankylosing spondylitis	0.0002	0.000913	CcSEcCtD
Zalcitabine—Chills—Methotrexate—ankylosing spondylitis	0.0002	0.000911	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000198	0.000903	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000198	0.000903	CcSEcCtD
Zalcitabine—Myalgia—Prednisone—ankylosing spondylitis	0.000198	0.0009	CcSEcCtD
Zalcitabine—Arthralgia—Prednisone—ankylosing spondylitis	0.000198	0.0009	CcSEcCtD
Zalcitabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000198	0.0009	CcSEcCtD
Zalcitabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000197	0.000898	CcSEcCtD
Zalcitabine—Anxiety—Prednisone—ankylosing spondylitis	0.000197	0.000897	CcSEcCtD
Zalcitabine—Alopecia—Methotrexate—ankylosing spondylitis	0.000197	0.000897	CcSEcCtD
Zalcitabine—Insomnia—Betamethasone—ankylosing spondylitis	0.000197	0.000896	CcSEcCtD
Zalcitabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000197	0.000896	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000196	0.000891	CcSEcCtD
Zalcitabine—Discomfort—Prednisone—ankylosing spondylitis	0.000195	0.000889	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000192	0.000875	CcSEcCtD
Zalcitabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000191	0.000872	CcSEcCtD
Zalcitabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000191	0.000872	CcSEcCtD
Zalcitabine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00019	0.000868	CcSEcCtD
Zalcitabine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00019	0.000866	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00019	0.000865	CcSEcCtD
Zalcitabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00019	0.000863	CcSEcCtD
Zalcitabine—Oedema—Prednisone—ankylosing spondylitis	0.000189	0.000863	CcSEcCtD
Zalcitabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000189	0.000861	CcSEcCtD
Zalcitabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000189	0.000861	CcSEcCtD
Zalcitabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000189	0.000861	CcSEcCtD
Zalcitabine—Infection—Prednisone—ankylosing spondylitis	0.000188	0.000857	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—ankylosing spondylitis	0.000188	0.000855	CcSEcCtD
Zalcitabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000188	0.000854	CcSEcCtD
Zalcitabine—Fatigue—Betamethasone—ankylosing spondylitis	0.000188	0.000854	CcSEcCtD
Zalcitabine—Shock—Prednisone—ankylosing spondylitis	0.000186	0.000849	CcSEcCtD
Zalcitabine—Pain—Betamethasone—ankylosing spondylitis	0.000186	0.000847	CcSEcCtD
Zalcitabine—Pain—Dexamethasone—ankylosing spondylitis	0.000186	0.000847	CcSEcCtD
Zalcitabine—Tachycardia—Prednisone—ankylosing spondylitis	0.000185	0.000842	CcSEcCtD
Zalcitabine—Skin disorder—Prednisone—ankylosing spondylitis	0.000184	0.000838	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000183	0.000834	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000183	0.000833	CcSEcCtD
Zalcitabine—Anorexia—Prednisone—ankylosing spondylitis	0.000181	0.000823	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00082	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—ankylosing spondylitis	0.000179	0.000817	CcSEcCtD
Zalcitabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000179	0.000817	CcSEcCtD
Zalcitabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000179	0.000817	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000178	0.00081	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000178	0.00081	CcSEcCtD
Zalcitabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000177	0.000805	CcSEcCtD
Zalcitabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000176	0.000803	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—ankylosing spondylitis	0.000175	0.000797	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—ankylosing spondylitis	0.000174	0.000794	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000174	0.000791	CcSEcCtD
Zalcitabine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000173	0.000787	CcSEcCtD
Zalcitabine—Urticaria—Betamethasone—ankylosing spondylitis	0.000173	0.000787	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000173	0.000786	CcSEcCtD
Zalcitabine—Dizziness—Prednisolone—ankylosing spondylitis	0.000172	0.000785	CcSEcCtD
Zalcitabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000172	0.000784	CcSEcCtD
Zalcitabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000172	0.000783	CcSEcCtD
Zalcitabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000172	0.000783	CcSEcCtD
Zalcitabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000172	0.000783	CcSEcCtD
Zalcitabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000172	0.000783	CcSEcCtD
Zalcitabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000172	0.000782	CcSEcCtD
Zalcitabine—Insomnia—Prednisone—ankylosing spondylitis	0.000171	0.000781	CcSEcCtD
Zalcitabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00017	0.000773	CcSEcCtD
Zalcitabine—Cough—Methotrexate—ankylosing spondylitis	0.000169	0.000771	CcSEcCtD
Zalcitabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000169	0.000771	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—ankylosing spondylitis	0.000168	0.000766	CcSEcCtD
Zalcitabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000167	0.00076	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000165	0.000752	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—ankylosing spondylitis	0.000165	0.000752	CcSEcCtD
Zalcitabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000165	0.00075	CcSEcCtD
Zalcitabine—Rash—Prednisolone—ankylosing spondylitis	0.000164	0.000749	CcSEcCtD
Zalcitabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000164	0.000748	CcSEcCtD
Zalcitabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000164	0.000746	CcSEcCtD
Zalcitabine—Fatigue—Prednisone—ankylosing spondylitis	0.000163	0.000744	CcSEcCtD
Zalcitabine—Headache—Prednisolone—ankylosing spondylitis	0.000163	0.000744	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—ankylosing spondylitis	0.000163	0.000743	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—ankylosing spondylitis	0.00016	0.000727	CcSEcCtD
Zalcitabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000159	0.000722	CcSEcCtD
Zalcitabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000158	0.000721	CcSEcCtD
Zalcitabine—Infection—Methotrexate—ankylosing spondylitis	0.000157	0.000717	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000156	0.000711	CcSEcCtD
Zalcitabine—Asthenia—Betamethasone—ankylosing spondylitis	0.000156	0.000711	CcSEcCtD
Zalcitabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000156	0.000711	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000155	0.000706	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000155	0.000706	CcSEcCtD
Zalcitabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000154	0.000701	CcSEcCtD
Zalcitabine—Pruritus—Betamethasone—ankylosing spondylitis	0.000154	0.000701	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000154	0.000701	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000153	0.000697	CcSEcCtD
Zalcitabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000152	0.000694	CcSEcCtD
Zalcitabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000152	0.000693	CcSEcCtD
Zalcitabine—Rash—Triamcinolone—ankylosing spondylitis	0.000151	0.000689	CcSEcCtD
Zalcitabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000151	0.000688	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—ankylosing spondylitis	0.000151	0.000687	CcSEcCtD
Zalcitabine—Rash—Methylprednisolone—ankylosing spondylitis	0.000151	0.000687	CcSEcCtD
Zalcitabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000151	0.000686	CcSEcCtD
Zalcitabine—Urticaria—Prednisone—ankylosing spondylitis	0.00015	0.000686	CcSEcCtD
Zalcitabine—Headache—Triamcinolone—ankylosing spondylitis	0.00015	0.000684	CcSEcCtD
Zalcitabine—Headache—Methylprednisolone—ankylosing spondylitis	0.00015	0.000683	CcSEcCtD
Zalcitabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00015	0.000682	CcSEcCtD
Zalcitabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00015	0.000682	CcSEcCtD
Zalcitabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000149	0.000678	CcSEcCtD
Zalcitabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000149	0.000678	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000144	0.000657	CcSEcCtD
Zalcitabine—Dizziness—Betamethasone—ankylosing spondylitis	0.000144	0.000655	CcSEcCtD
Zalcitabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000144	0.000655	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—ankylosing spondylitis	0.000143	0.000652	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000141	0.000643	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—ankylosing spondylitis	0.000141	0.000641	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00014	0.000636	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000139	0.000635	CcSEcCtD
Zalcitabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000138	0.00063	CcSEcCtD
Zalcitabine—Vomiting—Betamethasone—ankylosing spondylitis	0.000138	0.00063	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000138	0.000627	CcSEcCtD
Zalcitabine—Rash—Betamethasone—ankylosing spondylitis	0.000137	0.000625	CcSEcCtD
Zalcitabine—Rash—Dexamethasone—ankylosing spondylitis	0.000137	0.000625	CcSEcCtD
Zalcitabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000137	0.000624	CcSEcCtD
Zalcitabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000137	0.000624	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—ankylosing spondylitis	0.000136	0.000622	CcSEcCtD
Zalcitabine—Headache—Betamethasone—ankylosing spondylitis	0.000136	0.000621	CcSEcCtD
Zalcitabine—Headache—Dexamethasone—ankylosing spondylitis	0.000136	0.000621	CcSEcCtD
Zalcitabine—Asthenia—Prednisone—ankylosing spondylitis	0.000136	0.000619	CcSEcCtD
Zalcitabine—Pain—Methotrexate—ankylosing spondylitis	0.000135	0.000617	CcSEcCtD
Zalcitabine—Pruritus—Prednisone—ankylosing spondylitis	0.000134	0.000611	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00013	0.000594	CcSEcCtD
Zalcitabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00013	0.00059	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000129	0.00059	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—ankylosing spondylitis	0.000126	0.000573	CcSEcCtD
Zalcitabine—Dizziness—Prednisone—ankylosing spondylitis	0.000125	0.000571	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000125	0.00057	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000125	0.00057	CcSEcCtD
Zalcitabine—Vomiting—Prednisone—ankylosing spondylitis	0.00012	0.000549	CcSEcCtD
Zalcitabine—Rash—Prednisone—ankylosing spondylitis	0.000119	0.000544	CcSEcCtD
Zalcitabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000119	0.000544	CcSEcCtD
Zalcitabine—Headache—Prednisone—ankylosing spondylitis	0.000119	0.000541	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000117	0.000531	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000114	0.000517	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000112	0.00051	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000108	0.000493	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—ankylosing spondylitis	0.000105	0.000477	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000101	0.000459	CcSEcCtD
Zalcitabine—Rash—Methotrexate—ankylosing spondylitis	9.98e-05	0.000455	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—ankylosing spondylitis	9.97e-05	0.000454	CcSEcCtD
Zalcitabine—Headache—Methotrexate—ankylosing spondylitis	9.92e-05	0.000452	CcSEcCtD
